Therapeutic strategy of neuroendocrine tumours;Stratégie de traitement des tumeurs neuro-endocrines

Revue du Praticien

Volumn 52, Issue 3, 2002, Pages 290-296

  Ducreux, Miçhel ^a   Baudin, Eric ^a   Schlumberger, Martin ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; ETOPOSIDE; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN;

ARTIFICIAL EMBOLISM; CARCINOID SYNDROME; DISEASE COURSE; GASTRINOMA; HEALTH CARE QUALITY; HEMICOLECTOMY; LIVER METASTASIS; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; REVIEW; TUMOR DIFFERENTIATION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; GASTRINOMA; GROWTH HORMONE; HORMONES; HUMANS; MALIGNANT CARCINOID SYNDROME; MULTIPLE ENDOCRINE NEOPLASIA; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; STREPTOZOCIN;

EID: 0036469517     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Treatrnent of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue
2. The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors
3. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome
4. Treatment of the carcinoid syndrome with the Iongacting somatostatin analogue lanreotide: A prospective study in 39 patients
5. Somatostatin analogues in the management of endocrine tumours of the pancreas
6. Transcatheter chemoembolization of progressive carcinoid liver metastasis
7. An analysis of 8 305 cases of carcinoid tumours
8. Surgical treatment of carcinoid tumours of the stomach and small intestine
9. Surgery to cure the Zollinger-Ellison syndrome
10. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract
11. Streptozotocin-doxorubicin, streptozotocin-fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma
12. Islet cell tumours metastatic to the liver: Effective palliation with sequential hepatic artery embolization
13. Streptozotocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumour
14. Chemotherapy for metastatic tumours: An ECOG phase II-III trial
15. The antitumoral effect of the longacting somatostatin analog lanreotide in neuroendocrine tumours
16. Clinical efficacy of octreotide in the treatment of neuroendocrine tumours. A study by the Italian Trials in Medical Oncology Group
17. Therapy of metastatic carcinoid tumour and the malignant carcinoid syndrome with recombinant leukocyte A interferon
18. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
19. Chirurgie majeure et chimiothérapie réductionnelles dans les apudomes polymétastatiques
20. Hepatic resection for metastatic neuroendocrine carcinomas
21. Liver transplantation for metastatic neuroendocrine carcinoma: An analysis of 103 patients
22. Results of liver transplantation in the treatment of metastatic neuroendocrine tumours. A 31-case French multicentric report
23. Insulinomas in multiple endocrine neoplasia type I. Report of a series of 44 cases by the multiple endocrine neoplasia study group